Michel Ntemgwa
- Virology top 1%
- HIV Research and Treatment 13
- Molecular Medicine top 1%
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 13
- HIV/AIDS Research and Interventions 9
- Viral gastroenteritis research and epidemiology 1
- SARS-CoV-2 and COVID-19 Research 1
- Geriatrics and Gerontology top 5%
-
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- COVID-19 epidemiological studies 1
-
- ICT in Developing Communities 1
- Co-authors
- James A. AyukekbongMark A. WainbergBluma BrennerDaniela MoïsiMaureen OliveiraJean‐Pierre RoutyRéjean ThomasRoger LeBlanc
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)AIDS Research and Human Retroviruses (2 papers)AIDS (1 paper)
- Partner nations
- CanadaIvory CoastCameroon
In The Last Decade
Michel Ntemgwa
17 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Applied Microbiology and Biotechnology 393
- Virology 765
- Molecular Medicine 348
- Infectious Diseases 953
- Geriatrics and Gerontology 56
Countries citing papers authored by Michel Ntemgwa
This map shows the geographic impact of Michel Ntemgwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Ntemgwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Ntemgwa more than expected).
Fields of papers citing papers by Michel Ntemgwa
This network shows the impact of papers produced by Michel Ntemgwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Ntemgwa. The network helps show where Michel Ntemgwa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michel Ntemgwa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 4 | |
| 2 | 2017 | 4 | |
| 3 | The threat of antimicrobial resistance in developing countries: causes and control strategiesbreakdown → | 2017 | 878 |
| 4 | 2010 | 1 | |
| 5 | 2009 | 9 | |
| 6 | 2009 | 43 | |
| 7 | 2009 | 65 | |
| 8 | 2009 | 27 | |
| 9 | 2008 | 11 | |
| 10 | 2008 | 3 | |
| 11 | 2008 | 8 | |
| 12 | 2008 | 23 | |
| 13 | High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infectionbreakdown → | 2007 | 501 |
| 14 | 2007 | 27 | |
| 15 | 2006 | 174 | |
| 16 | 2006 | 3 | |
| 17 | 2006 | 53 |
About Michel Ntemgwa
Michel Ntemgwa is a scholar working on Virology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 17 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Viral gastroenteritis research and epidemiology (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), COVID-19 epidemiological studies (1 paper) and ICT in Developing Communities (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (393 citations), Virology (765 citations) and Molecular Medicine (348 citations). Michel Ntemgwa has collaborated with scholars based in Canada, Ivory Coast and Cameroon. Frequent co-authors include James A. Ayukekbong, Mark A. Wainberg, Bluma Brenner, Daniela Moïsi, Maureen Oliveira, Jean‐Pierre Routy, Réjean Thomas, Roger LeBlanc, Hugues Charest and Jean‐Guy Baril. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, AIDS Research and Human Retroviruses, AIDS, Journal of the International AIDS Society and Antimicrobial Resistance and Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.